NEREUS PHARMACEUTICALS

nereus-pharmaceuticals-logo

Nereus Pharmaceuticals, Inc. engages in the discovery and development of therapeutics for the treatment of oncology, infectious diseases, and inflammation. The company uses its marine microbiology technologies for the discovery and development of drug candidates. Its oncology drug candidates include NPI-2358, a tumor vascular disrupting agent for the treatment of solid tumors; and NPI-0052, a proteasome inhibitor for the treatment of solid tumors, lymphomas, and multiple myeloma. The company was founded in 1998 and is based in San Diego, California.

#SimilarOrganizations #People #Financial #Website #More

NEREUS PHARMACEUTICALS

Industry:
Biotechnology Health Care Medical

Founded:
1998-01-01

Address:
San Diego, California, United States

Country:
United States

Website Url:
http://www.nereuspharm.com

Total Employee:
11+

Status:
Active

Contact:
19999999999

Email Addresses:
[email protected]

Total Funding:
139.8 M USD

Technology used in webpage:
SPF Microsoft Exchange Online GoDaddy Network Solutions DNS


Similar Organizations

capulus-therapeutics-logo

Capulus Therapeutics

Capulus Therapeutics engages in drug discovery and development with a predictive AI guided approach to target the root cause of diseases.

fedora-pharmaceuticals-logo

Fedora Pharmaceuticals

Fedora Pharmaceuticals engages in the discovery and development of antibiotics for life-threatening microbial drug resistance needs.

multiple-myeloma-research-foundation-logo

Multiple Myeloma Research Foundation

The MMRF relentlessly pursues innovative means that accelerate the development of next-generation multiple myeloma treatments to extend

not_available_image

NAEJA-RGM Pharmaceuticals

NAEJA-RGM Pharmaceuticals engages in proprietary drug discovery work and is a player in the field of infectious disease research.


Current Advisors List

jason-fisherman_image

Jason Fisherman Member of the Board of Directors @ Nereus Pharmaceuticals
Board_member

jim-van-heusden_image

Jim Van heusden Board memeber @ Nereus Pharmaceuticals
Board_member

Current Employees Featured

standish-m-fleming_image

Standish M. Fleming
Standish M. Fleming Founder @ Nereus Pharmaceuticals
Founder

not_available_image

G. Kenneth Lloyd
G. Kenneth Lloyd Senior Vice President, R & D, and CSO @ Nereus Pharmaceuticals
Senior Vice President, R & D, and CSO

kobi-m-sethna_image

Kobi M. Sethna
Kobi M. Sethna Founder, President & CEO @ Nereus Pharmaceuticals
Founder, President & CEO

not_available_image

William H. Fenical
William H. Fenical Founder @ Nereus Pharmaceuticals
Founder

martin-rosenberg_image

Martin Rosenberg
Martin Rosenberg Director @ Nereus Pharmaceuticals
Director

Founder


kobi-m-sethna_image

Kobi M. Sethna

michael-a-palladino_image

Michael A. Palladino

standish-m-fleming_image

Standish M. Fleming

not_available_image

William H. Fenical

Investors List

pacific-venture-group_image

Pacific Venture Group

Pacific Venture Group investment in Series E - Nereus Pharmaceuticals

forward-ventures_image

Forward Ventures

Forward Ventures investment in Series E - Nereus Pharmaceuticals

alta-partners_image

Alta Partners

Alta Partners investment in Series E - Nereus Pharmaceuticals

hbm-healthcare-investments-ag_image

HBM Healthcare Investments AG

HBM Healthcare Investments AG investment in Series E - Nereus Pharmaceuticals

astellas-venture-management_image

Astellas Venture Management

Astellas Venture Management investment in Series E - Nereus Pharmaceuticals

roche-venture-fund_image

Roche Venture Fund

Roche Venture Fund investment in Series E - Nereus Pharmaceuticals

advent-international_image

Advent International

Advent International investment in Series E - Nereus Pharmaceuticals

hbm-healthcare-investments-ag_image

HBM Healthcare Investments AG

HBM Healthcare Investments AG investment in Series D - Nereus Pharmaceuticals

roche-venture-fund_image

Roche Venture Fund

Roche Venture Fund investment in Series D - Nereus Pharmaceuticals

astellas-venture-management_image

Astellas Venture Management

Astellas Venture Management investment in Series D - Nereus Pharmaceuticals

Official Site Inspections

http://www.nereuspharm.com

  • Host name: 98.220.74.97.host.secureserver.net
  • IP address: 97.74.220.98
  • Location: Scottsdale United States
  • Latitude: 33.6013
  • Longitude: -111.8867
  • Metro Code: 753
  • Timezone: America/Phoenix
  • Postal: 85260

Loading ...

More informations about "Nereus Pharmaceuticals"

Nereus Pharmaceuticals - Wikipedia

Nereus Pharmaceuticals was a pharmaceutical company focused on the development of natural products from marine microbial and other natural sources into small molecule human therapeutics. The major disease area addressed by Nereus is cancer. Nereus was purchased by Triphase Research and Development in 2012. See details»

Nereus Pharmaceuticals - Crunchbase Company Profile โ€ฆ

Contact Email [email protected] Nereus Pharmaceuticals, Inc. engages in the discovery and development of therapeutics for the treatment of oncology, โ€ฆSee details»

Nereus Pharmaceuticals - Products, Competitors, Financials, โ€ฆ

Nereus Pharmaceuticals is a drug discovery and development company pursuing sources of chemical diversity through identifying drug candidates derived from marine microbes.See details»

Nereus Pharmaceuticals - VentureRadar

Website: http://www.nereuspharm.com. Nereus Pharmaceuticals is a US pharmaceuticals R&D company that was set up in 1999 to explore new candidate substances. Nereus obtains these โ€ฆSee details»

Nereus Pharmaceuticals Inc. Information

Http://www.nereuspharm.com Company Information: Nereus Pharmaceuticals Inc., is located at San Diego, CA and is an innovative drug discovery and development company pursuing โ€ฆSee details»

Nereus Pharmaceuticals - Overview, News & Similar companies

View Nereus Pharmaceuticals (www.nereuspharm.com) location in California, United States , revenue, industry and description. Find related and similar companies as well as employees โ€ฆSee details»

Nereus Pharmaceuticals Inc., Kobi M. Sethna,

[email protected]: Phone: 1-858-587-4090: Website: www.nereuspharm.com Fax: 1-858-587-4088: Summary ; Executive Details ; Board Members ; Business Information The groupโ€™s โ€ฆSee details»

About: Nereus Pharmaceuticals - DBpedia Association

Nereus Pharmaceuticals was a pharmaceutical company focused on the development of natural products from and other natural sources into small molecule human therapeutics. The major โ€ฆSee details»

Nereus Pharmaceuticals - Ownership and Business Overview

Jan 2, 2012ย ยท Who owns Nereus Pharmaceuticals? Nereus Pharmaceuticals is owned by Triphase Accelerator. It was acquired on January 2, 2012. Was Nereus Pharmaceuticals โ€ฆSee details»

Nereus Pharmaceuticals - WikiMili, The Best Wikipedia Reader

Apr 24, 2022ย ยท Nereus Pharmaceuticals was a pharmaceutical company focused on the development of natural products from marine microbial and other natural sources into small โ€ฆSee details»

Nereus Pharmaceuticals Completes Enrollment of Phase 2 โ€ฆ

Jun 22, 2010ย ยท The company's discovery portfolio includes potential drug candidates for cancer, infectious diseases and inflammation. For more information, visit www.nereuspharm.com.See details»

Nereus Pharma Company Profile 2024: Valuation, Funding

Developer of innovative pharmaceutical products designed for the aquaculture industry. The company's products include a new antibiotic formulation which reduces environmental โ€ฆSee details»

Nereus Pharmaceuticals Initiates Clinical Trial of NPI-2358 in Non ...

Mar 20, 2008ย ยท Nereus Pharmaceuticals pursues novel sources of chemical diversity to discover and develop new therapeutics. Using its unmatched expertise in marine microbiology to โ€ฆSee details»

Award - SBIR

An official website of the United States government. Hereโ€™s how you knowSee details»

Nereus Therapeutics Company Profile 2024: Valuation, Funding ...

Information on valuation, funding, cap tables, investors, and executives for Nereus Therapeutics. Use the PitchBook Platform to explore the full profile.See details»

PRESS RELEASE: Nereus Pharmaceuticals Raises $45 ... - Fierce โ€ฆ

SAN DIEGO, Aug. 9 -- Nereus Pharmaceuticals, Inc., a pioneer in the use of marine microbial sources for the discovery and development of cancer therapeutics, today announced it raised โ€ฆSee details»

Nereus Pharmaceuticals, Inc. Completes Enrollment of Phase 2

SAN DIEGO, June 22 /PRNewswire/ -- Nereus Pharmaceuticals, Inc., a pioneer in drug discovery and development from marine microbial sources, announced completion of enrollment in the โ€ฆSee details»

Nereus Pharmaceuticals, Inc. Initiates Clinical Trial of NPI

SAN DIEGO, March 20 /PRNewswire/ -- Nereus Pharmaceuticals, Inc., a pioneer in drug discovery from marine microbial sources, today announced that enrollment has begun in a โ€ฆSee details»

Nereus Pharmaceuticals, Inc. Initiates ADVANCE, a Randomized

SAN DIEGO, March 23 /PRNewswire/ -- Nereus Pharmaceuticals, Inc., a pioneer in drug discovery from marine microbial sources, today announced that it is conducting a randomized โ€ฆSee details»

linkstock.net © 2022. All rights reserved